Scaling Bispecific Antibody Production: Expert Insights from Avid Bioservices

The upcoming webinar, hosted by Xtalks, features Dave Briggs of Avid Bioservices, who will provide a technical deep dive into the manufacturing lifecycle of bispecific antibodies. As these molecules engage two targets simultaneously, development teams face the persistent challenge of managing mispaired and incomplete antibody species. The session will outline how early-stage design choices impact downstream manufacturability and product quality.

Briggs will examine the integration of cell line development and analytical characterization in maintaining product consistency. A core focus will be the purification process, specifically the design of chromatography workflows intended to isolate the desired molecular structure. By analyzing real-world examples of process optimization, the presentation aims to clarify how robust characterization supports reliable performance as programs scale toward clinical and commercial manufacturing requirements.